(4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride has been researched along with Decerebrate Posturing in 4 studies
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride: A drug that selectively activates certain subclasses of muscarinic receptors and also activates postganglionic nicotinic receptors. It is commonly used experimentally to distinguish muscarinic receptor subtypes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, P | 1 |
| Cantalamessa, F | 1 |
| Gulini, U | 1 |
| Melchiorre, C | 1 |
| Giachetti, A | 1 |
| Giraldo, E | 1 |
| Ladinsky, H | 1 |
| Montagna, E | 1 |
| Rechtman, MP | 1 |
| Ishac, EJ | 1 |
| Boura, AL | 1 |
| King, RG | 1 |
| Walters, WA | 1 |
| Wong-Dusting, H | 1 |
| Rand, MJ | 1 |
4 other studies available for (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride and Decerebrate Posturing
| Article | Year |
|---|---|
Selective blockade of muscarinic M2 receptors in vivo by the new antagonist tripitramine.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Benzodiazepines; Bloo | 1995 |
Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Blood Pressure; Cyclo | 1986 |
Attenuation of pressor responses to sympathetic stimuli in the rat by enalapril.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Blood Pressure; Decer | 1986 |
Inhibition of sympathetic neurotransmission by the opioid delta-receptor agonist DAMA in the pithed rat.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Blood Pressure; Decer | 1989 |